Koen holds a PhD in molecular biology from Yale University, where he focused on developing bioengineering strategies to improve pharmacokinetics of biologics.

Prior to joining as a Blavatnik Fellow, Koen worked as a project leader at The Boston Consulting Group (BCG). While at BCG, he gained experience working with senior leaders in large- and medium-sized pharmaceutical and medtech companies on topics ranging from R&D strategy, manufacturing optimization and commercial go-to-market strategies, as well as project management for large company transformations.